Zhu Lijun, Lu Linlin, Zeng Shan, Luo Feifei, Dai Peimin, Wu Peng, Wang Ying, Liu Liang, Hu Ming, Liu Zhongqiu
International Institute for Translational Chinese Medicine, Guangzhou University of Chinese Medicine, Guangzhou, Guangdong, PR China (Z.L.J., L.L.L., Z.S., L.F.F., D.P.M., W.P., W.Y., H.M., L.Z.Q.); Department of Pharmacological and Pharmaceutical Sciences, College of Pharmacy, University of Houston, Houston, Texas (H.M.); Department of Pharmaceutics, School of Pharmaceutical Sciences, Southern Medical University, Guangzhou, Guangdong, PR China (D.P.M., W.Y.); and State Key Laboratory of Quality Research in Chinese Medicine, Macau University of Science and Technology, Macau (SAR), PR China (L.L.).
International Institute for Translational Chinese Medicine, Guangzhou University of Chinese Medicine, Guangzhou, Guangdong, PR China (Z.L.J., L.L.L., Z.S., L.F.F., D.P.M., W.P., W.Y., H.M., L.Z.Q.); Department of Pharmacological and Pharmaceutical Sciences, College of Pharmacy, University of Houston, Houston, Texas (H.M.); Department of Pharmaceutics, School of Pharmaceutical Sciences, Southern Medical University, Guangzhou, Guangdong, PR China (D.P.M., W.Y.); and State Key Laboratory of Quality Research in Chinese Medicine, Macau University of Science and Technology, Macau (SAR), PR China (L.L.)
Drug Metab Dispos. 2015 Jul;43(7):977-83. doi: 10.1124/dmd.115.063552. Epub 2015 Apr 8.
Esculetin (6,7-dihydroxycoumarin, ET) and 4-methylesculetin (6,7-dihydroxy-4-methylcoumarin, 4-ME) are typical coumarin derivatives that are attracting considerable attention because of their wide spectrum of biologic activities, but their metabolism remains unknown. This study aimed to elucidate the in vitro UDP-glucuronosyltransferase (UGT) metabolism characteristics of ET and 4-ME. 7-O-monoglucuronide esculetin (ET-G) and 7-O-monoglucuronide 4-methylesculetin (4-ME-G) were identified by liquid chromatography-mass spectrometry (LC-MS) and (1)H-nuclear magnetic resonance ((1)HNMR) when ET or 4-ME was incubated with human liver (HLM) in the presence of UDP-glucuronic acid. Screening assays with 12 human expressed UGTs demonstrated that the formations of ET-G and 4-ME-G were almost exclusively catalyzed by UGT1A6 and UGT1A9. Phenylbutazone and carvacrol (UGT1A6 and UGT1A9 chemical inhibitors, respectively) at different concentrations (50, 100, and 200 μM) significantly inhibited the formation of glucuronidates of ET and 4-ME in HLM, UGT1A6, and UGT1A9 when the concentrations of ET and 4-ME ranged from 10 to 300 μM (P < 0.05). Clearance rates of ET in HLM, HIM, UGT1A6, and UGT1A9 were 0.54, 0.16, 0.69, and 0.14 ml/min/mg, respectively. Corresponding clearance rates values of 4-ME were 0.59, 0.03, 0.14, and 0.04 ml/min/mg, respectively. In conclusion, 7-O-monoglucuronidation by UGT1A6 and UGT1A9 was the predominant UGT metabolic pathway for both ET and 4-ME in vitro. The liver is probably the major contributor to the glucuronidation metabolism of ET and 4-ME. ET showed more rapid metabolism than 4-ME in glucuronidation.
七叶亭(6,7 - 二羟基香豆素,ET)和4 - 甲基七叶亭(6,7 - 二羟基 - 4 - 甲基香豆素,4 - ME)是典型的香豆素衍生物,因其广泛的生物活性而备受关注,但其代谢情况尚不清楚。本研究旨在阐明ET和4 - ME在体外的尿苷二磷酸葡萄糖醛酸基转移酶(UGT)代谢特征。当ET或4 - ME在尿苷二磷酸葡萄糖醛酸存在的情况下与人肝微粒体(HLM)一起孵育时,通过液相色谱 - 质谱联用(LC - MS)和氢核磁共振(¹HNMR)鉴定出7 - O - 单葡萄糖醛酸七叶亭(ET - G)和7 - O - 单葡萄糖醛酸4 - 甲基七叶亭(4 - ME - G)。对12种人源表达的UGT进行的筛选试验表明,ET - G和4 - ME - G的形成几乎完全由UGT1A6和UGT1A9催化。不同浓度(50、100和200μM)的保泰松和香芹酚(分别为UGT1A6和UGT1A9的化学抑制剂)在ET和4 - ME浓度范围为10至300μM时,显著抑制了HLM、UGT1A6和UGT1A9中ET和4 - ME葡萄糖醛酸苷的形成(P < 0.05)。ET在HLM、人肝微粒体(HIM)、UGT1A6和UGT1A9中的清除率分别为0.54、0.16、0.69和0.14 ml/min/mg。4 - ME的相应清除率值分别为0.59、0.03、0.14和0.04 ml/min/mg。总之,UGT1A6和UGT1A9催化的7 - O - 单葡萄糖醛酸化是ET和4 - ME在体外主要的UGT代谢途径。肝脏可能是ET和4 - ME葡萄糖醛酸化代谢的主要贡献者。在葡萄糖醛酸化过程中,ET的代谢比4 - ME更快。